(UBSG) UBS - Ratings and Ratios
Investment, Banking, Wealth, Management, Finance
UBSG EPS (Earnings per Share)
UBSG Revenue
Description: UBSG UBS
UBS Group AG is a global financial services company providing a wide range of financial solutions to private, institutional, and corporate clients. The company operates through five divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-core and Legacy. Its diverse offerings include investment advice, wealth planning, corporate banking, investment management, and various lending solutions.
Key Performance Indicators (KPIs) for UBS Group AG include a market capitalization of approximately 85.6 billion CHF, indicating its significant presence in the global financial sector. The companys Price-to-Earnings (P/E) ratio is 22.19, suggesting a moderate valuation relative to its earnings. The forward P/E ratio of 16.72 implies expected earnings growth. The Return on Equity (RoE) of 5.86% indicates the companys ability to generate profits from shareholders equity.
From a strategic perspective, UBS Group AGs diversified business model across wealth management, asset management, and investment banking positions it well for long-term sustainability. The companys global footprint and comprehensive financial solutions enable it to capitalize on growth opportunities across different markets and client segments. Its ability to provide advisory services on strategic business opportunities and capital raising further enhances its value proposition to corporate clients.
Operationally, UBS Group AGs focus on providing a broad range of financial products and services, including equities, fixed income, hedge funds, and alternative investment strategies, allows it to cater to diverse client needs. The companys capabilities in managing risks, liquidity, and capital markets also support its clients financial goals and objectives.
UBSG Stock Overview
| Market Cap in USD | 127,600m |
| Sub-Industry | Diversified Banks |
| IPO / Inception |
UBSG Stock Ratings
| Growth Rating | 74.1% |
| Fundamental | 54.4% |
| Dividend Rating | 27.7% |
| Return 12m vs S&P 500 | 7.15% |
| Analyst Rating | - |
UBSG Dividends
| Dividend Yield 12m | 1.23% |
| Yield on Cost 5y | 3.68% |
| Annual Growth 5y | -9.28% |
| Payout Consistency | 69.2% |
| Payout Ratio | 20.0% |
UBSG Growth Ratios
| Growth Correlation 3m | 93.1% |
| Growth Correlation 12m | 32.1% |
| Growth Correlation 5y | 95.3% |
| CAGR 5y | 26.69% |
| CAGR/Max DD 5y | 0.83 |
| Sharpe Ratio 12m | 1.03 |
| Alpha | 5.87 |
| Beta | 1.196 |
| Volatility | 23.75% |
| Current Volume | 5177.9k |
| Average Volume 20d | 5391.2k |
| Stop Loss | 31.6 (-3%) |
| Signal | 1.47 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (6.28b TTM) > 0 and > 6% of Revenue (6% = 3.55b TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -4.42pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1217 % (prev 553.4%; Δ -1770 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 12.31b > Net Income 6.28b (YES >=105%, WARN >=100%) |
| Net Debt (129.94b) to EBITDA (9.33b) ratio: 13.92 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.29 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (3.31b) change vs 12m ago -1.57% (target <= -2.0% for YES) |
| Gross Margin 47.13% (prev 98.78%; Δ -51.65pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 3.66% (prev 2.88%; Δ 0.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.19 (EBITDA TTM 9.33b / Interest Expense TTM 30.67b) >= 6 (WARN >= 3) |
Altman Z'' -2.59
| (A) -0.43 = (Total Current Assets 290.71b - Total Current Liabilities 1010.57b) / Total Assets 1669.99b |
| (B) 0.05 = Retained Earnings (Balance) 79.73b / Total Assets 1669.99b |
| (C) 0.00 = EBIT TTM 5.72b / Avg Total Assets 1615.48b |
| (D) 0.05 = Book Value of Equity 85.55b / Total Liabilities 1580.29b |
| Total Rating: -2.59 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.42
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield 4.10% = 2.05 |
| 3. FCF Margin 17.08% = 4.27 |
| 4. Debt/Equity 4.08 = -2.09 |
| 5. Debt/Ebitda 39.03 = -2.50 |
| 6. ROIC - WACC -2.73% = -3.41 |
| 7. RoE 7.21% = 0.60 |
| 8. Rev. Trend 90.93% = 4.55 |
| 9. Rev. CAGR 35.47% = 2.50 |
| 10. EPS Trend -13.85% = -0.35 |
| 11. EPS CAGR 13.02% = 1.30 |
What is the price of UBSG shares?
Over the past week, the price has changed by +2.20%, over one month by +7.31%, over three months by +24.02% and over the past year by +26.09%.
Is UBS a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UBSG is around 37.23 CHF . This means that UBSG is currently undervalued and has a potential upside of +14.27% (Margin of Safety).
Is UBSG a buy, sell or hold?
What are the forecasts/targets for the UBSG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.9 | -2.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 39.7 | 22% |
UBSG Fundamental Data Overview
Market Cap USD = 127.60b (102.30b CHF * 1.2473 CHF.USD)
CCE Cash And Equivalents = 245.66b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 21.2368
P/E Forward = 21.692
P/S = 2.1761
P/B = 1.4334
P/EG = 0.398
Beta = 0.918
Revenue TTM = 59.17b USD
EBIT TTM = 5.72b USD
EBITDA TTM = 9.33b USD
Long Term Debt = 307.98b USD (from longTermDebt, last quarter)
Short Term Debt = 56.31b USD (from shortTermDebt, last quarter)
Debt = 364.29b USD (Calculated: Short Term 56.31b + Long Term 307.98b)
Net Debt = 129.94b USD (from netDebt column, last quarter)
Enterprise Value = 246.23b USD (127.60b + Debt 364.29b - CCE 245.66b)
Interest Coverage Ratio = 0.19 (Ebit TTM 5.72b / Interest Expense TTM 30.67b)
FCF Yield = 4.10% (FCF TTM 10.11b / Enterprise Value 246.23b)
FCF Margin = 17.08% (FCF TTM 10.11b / Revenue TTM 59.17b)
Net Margin = 10.62% (Net Income TTM 6.28b / Revenue TTM 59.17b)
Gross Margin = 47.13% ((Revenue TTM 59.17b - Cost of Revenue TTM 31.28b) / Revenue TTM)
Tobins Q-Ratio = 2.88 (Enterprise Value 246.23b / Book Value Of Equity 85.55b)
Interest Expense / Debt = 1.87% (Interest Expense 6.82b / Debt 364.29b)
Taxrate = 24.56% (from yearly Income Tax Expense: 1.68b / 6.82b)
NOPAT = 4.31b (EBIT 5.72b * (1 - 24.56%))
Current Ratio = 0.29 (Total Current Assets 290.71b / Total Current Liabilities 1010.57b)
Debt / Equity = 4.08 (Debt 364.29b / last Quarter total Stockholder Equity 89.28b)
Debt / EBITDA = 39.03 (Net Debt 129.94b / EBITDA 9.33b)
Debt / FCF = 36.05 (Debt 364.29b / FCF TTM 10.11b)
Total Stockholder Equity = 87.14b (last 4 quarters mean)
RoA = 0.38% (Net Income 6.28b, Total Assets 1669.99b )
RoE = 7.21% (Net Income TTM 6.28b / Total Stockholder Equity 87.14b)
RoCE = 1.45% (Ebit 5.72b / (Equity 87.14b + L.T.Debt 307.98b))
RoIC = 1.02% (NOPAT 4.31b / Invested Capital 422.76b)
WACC = 3.75% (E(127.60b)/V(491.89b) * Re(10.42%)) + (D(364.29b)/V(491.89b) * Rd(1.87%) * (1-Tc(0.25)))
Shares Correlation 5-Years: -20.0 | Cagr: -1.93%
Discount Rate = 10.42% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 60.55% ; FCFE base≈37.46b ; Y1≈24.59b ; Y5≈11.25b
Fair Price DCF = 49.57 (DCF Value 157.09b / Shares Outstanding 3.17b; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 90.93 | Revenue CAGR: 35.47%
Rev Growth-of-Growth: 3.49
EPS Correlation: -13.85 | EPS CAGR: 13.02%
EPS Growth-of-Growth: 178.0